Back
Annaly Capital Management Vs. Keros Therapeutics Industry Stock Comparison
Sell
38
NLY
Annaly Capital Management
Last Price:
19.90
Seasonality Move:
-2.01%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.20
Seasonality Move:
4.22%
Sell
38
Annaly Capital Management (NLY)
is a Sell
Is Annaly Capital Management a Buy, Sell or Hold?
- The current Annaly Capital Management [NLY] share price is $20.05. The Score for NLY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NLY Stock Price Chart
What is Annaly Capital Management's stock price today?
-
The Annaly Capital Management share price today is $20.05
The current trend is moderately bullish and NLY is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
NLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 55.15 | Buy |
| Chaikin Money Flow: | -2431883 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.53 - 20.11) | Buy |
| Bollinger Bands (100): | (18.73 - 19.95) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.91 | Sell |
| Relative Strength Index (14 RSI): | 36.74 | Sell |
| Chaikin Money Flow: | -120480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.18 - 50.06) | Sell |
| Bollinger Bands (100): | (50.42 - 64.92) | Sell |
NLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.07 | Sell |
| 20-day SMA: | 19.83 | Buy |
| 50-day SMA: | 19.47 | Buy |
| 200-day SMA: | 18.92 | Buy |
| 8-day EMA: | 20.01 | Buy |
| 20-day EMA: | 19.9 | Buy |
| 50-day EMA: | 19.66 | Buy |
| 200-day EMA: | 19.4 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.5 | Sell |
| 20-day SMA: | 47.57 | Sell |
| 50-day SMA: | 52.43 | Sell |
| 200-day SMA: | 46.94 | Sell |
| 8-day EMA: | 46.46 | Sell |
| 20-day EMA: | 48 | Sell |
| 50-day EMA: | 51.59 | Sell |
| 200-day EMA: | 50.14 | Sell |
Annaly Capital Management Earnings Growth & NLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Annaly Capital Management Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||